{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T14:28:00Z","timestamp":1778336880607,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006049","name":"omisi\u00f3n Sectorial de Investigaci\u00f3n Cient\u00edfica","doi-asserted-by":"publisher","award":["CSIC I+D 808"],"award-info":[{"award-number":["CSIC I+D 808"]}],"id":[{"id":"10.13039\/501100006049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008725","name":"Agencia Nacional de Investigaci\u00f3n e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["ANII POS_NAC_2014_1_102979"],"award-info":[{"award-number":["ANII POS_NAC_2014_1_102979"]}],"id":[{"id":"10.13039\/100008725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ejps.2017.09.006","type":"journal-article","created":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T15:15:17Z","timestamp":1504624517000},"page":"480-485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Methotrexate pharmacogenetics in Uruguayan adults with hematological malignant diseases"],"prefix":"10.1016","volume":"109","author":[{"given":"Andrea","family":"Giletti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Vital","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariana","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Cardozo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Borelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal","family":"Gabus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lem","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilian","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo","family":"Assar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Noel","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Esper\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2017.09.006_bb0005","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1158\/1078-0432.CCR-09-0641","article-title":"DNA variants in region for noncoding interfering transcript of dihydrofolate reductase gene and outcome in childhood acute lymphoblastic leukemia","volume":"15","author":"Al-Shakfa","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejps.2017.09.006_bb0010","doi-asserted-by":"crossref","first-page":"578","DOI":"10.2174\/138920210793360925","article-title":"Dihydrofolate reductase gene variations in susceptibility to disease and treatment outcomes","volume":"11","author":"Askari","year":"2010","journal-title":"Curr. Genomics"},{"key":"10.1016\/j.ejps.2017.09.006_bb0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00280-016-3043-5","article-title":"Methotrexate-induced toxicity pharmacogenetics: an umbrella review of systematic reviews and meta-analyses","volume":"78","author":"Campbell","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejps.2017.09.006_bb0020","first-page":"S5","article-title":"Mechanisms of action of methotrexate","volume":"71","author":"Chan","year":"2013","journal-title":"Bull. Hosp. Jt Dis."},{"key":"10.1016\/j.ejps.2017.09.006_bb0025","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1007\/s13277-015-3602-0","article-title":"Gene polymorphisms in the folate metabolism and their association with MTX-related adverse events in the treatment of ALL","volume":"36","author":"Chen","year":"2015","journal-title":"Tumor Biol."},{"issue":"3","key":"10.1016\/j.ejps.2017.09.006_bb0030","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00280-011-1751-4","article-title":"The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue","volume":"69","author":"Chiusolo","year":"2012","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejps.2017.09.006_bb0035","author":"Database of Single Nucleotide Polymorphisms (dbSNP)"},{"key":"10.1016\/j.ejps.2017.09.006_bb0040","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2217\/pgs.12.70","article-title":"Genetic variants of thiopurine and folate metabolic pathways determine 6-MP mediated hematological toxicity in childhood ALL","volume":"13","author":"Dorababu","year":"2012","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ejps.2017.09.006_bb0045","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1182\/blood-2007-09-110593","article-title":"DNA variants in the dihydrofolate reductase gene and outcome in childhood ALL","volume":"111","author":"Dulucq","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ejps.2017.09.006_bb0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/MBC.0b013e32835b249d","article-title":"C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: effect on methotrexate-related toxicity in adult acute lymphoblastic leukaemia","volume":"24","author":"Eissa","year":"2013","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"6","key":"10.1016\/j.ejps.2017.09.006_bb0055","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3109\/10428194.2011.639880","article-title":"Influence of folate pathway polymorphisms on high-dose methotrexate-related toxicity and survival in childhood acute lymphoblastic leukemia","volume":"53","author":"Er\u010dulj","year":"2012","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.ejps.2017.09.006_bb0060","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00228-011-1046-z","article-title":"Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma","volume":"67","author":"Faganel Kotnik","year":"2011","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejps.2017.09.006_bb0065","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejps.2017.09.006_bb0070","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0140-6736(09)61416-1","article-title":"High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial","volume":"374","author":"Ferreri","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ejps.2017.09.006_bb0075","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ctrv.2008.02.001","article-title":"Technological advances in mucositis research: new insights and new issues","volume":"34","author":"Gibson","year":"2008","journal-title":"Cancer Treat. Rev."},{"issue":"1","key":"10.1016\/j.ejps.2017.09.006_bb0080","article-title":"Homociste\u00edna, polimorfismos MTHFR C677T, A1298C y variables cl\u00ednico-bioqu\u00edmicas en poblaci\u00f3n mexicana","volume":"48","author":"Gonz\u00e1lez-Mercado","year":"2014","journal-title":"Acta Bioqu\u00edm. Cl\u00edn. Latinoam."},{"issue":"5","key":"10.1016\/j.ejps.2017.09.006_bb0085","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/tpj.2015.11","article-title":"Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate","volume":"15","author":"Jabeen","year":"2015","journal-title":"Pharmacogenomics J."},{"issue":"2","key":"10.1016\/j.ejps.2017.09.006_bb0090","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1124\/jpet.108.140475","article-title":"Increasing systemic exposure of methotrexate by active efflux mediated by multidrug resistance-associated protein 3 (Mrp3\/Abcc3)","volume":"327","author":"Kitamura","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2017.09.006_bb0100","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1158\/1078-0432.CCR-04-0169","article-title":"Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy","volume":"10","author":"Lecomte","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejps.2017.09.006_bb0110","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1182\/blood-2008-03-145128","volume":"112","author":"Mead","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ejps.2017.09.006_bb0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/oxfordjournals.aje.a115101","article-title":"A study of the impact of confounder-selection criteria on effect estimation","volume":"129","author":"Mickey","year":"1989","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.ejps.2017.09.006_bb0120","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3324\/haematol.2009.008326","article-title":"Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival","volume":"94","author":"Ongaro","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.ejps.2017.09.006_bb0125","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00277-007-0274-x","article-title":"Genetic polymorphisms of folate metabolic enzymes and toxicities of high dose methotrexate in children with acute lymphoblastic leukemia","volume":"86","author":"Pakakasama","year":"2007","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.ejps.2017.09.006_bb0130","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1182\/blood-2013-01-480335","article-title":"Germline genetic variations in methotrexate candidate genes are associated with pharmacokinetics, toxicity, and outcome in childhood acute lymphoblastic leukemia","volume":"121","author":"Radtke","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ejps.2017.09.006_bb0135","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1182\/blood-2012-08-452839","article-title":"Genome-wide study of methotrexate clearance replicates SLCO1B1","volume":"121","author":"Ramsey","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ejps.2017.09.006_bb0140","first-page":"572","article-title":"Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis","volume":"35","author":"Ranganathan","year":"2008","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ejps.2017.09.006_bb0145","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1182\/asheducation-2013.1.126","article-title":"Pharmacogenomics of acute lymphoid leukemia: new insights into treatment toxicity and efficacy","volume":"2013","author":"Relling","year":"2013","journal-title":"Hematology Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.ejps.2017.09.006_bb0150","first-page":"134","article-title":"Pharmacogenomics of serious adverse drug reactions in pediatric oncology","volume":"18","author":"Ross","year":"2011","journal-title":"J. Popul. Ther. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2017.09.006_bb0155","first-page":"163","article-title":"\u201cRaza\u201d, adscripci\u00f3n \u00e9tnica y gen\u00e9tica en Uruguay","volume":"30","author":"Sans","year":"2009","journal-title":"RUNA"},{"key":"10.1016\/j.ejps.2017.09.006_bb0160","author":"Sociedad Uruguaya de Hematolog\u00eda"},{"key":"10.1016\/j.ejps.2017.09.006_bb0165","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/FPC.0b013e32834ded2a","article-title":"Methylene tetrahydrofolate reductase gene polymorphisms and their association with methotrexate toxicity: a meta-analysis","volume":"22","author":"Spyridopoulou","year":"2012","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.ejps.2017.09.006_bb0170","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1200\/JCO.2013.48.6522","article-title":"Intensive chemotherapy for childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial ALL IC-BFM 2002","volume":"32","author":"Stary","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejps.2017.09.006_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2014.03.221","article-title":"P0177 Impact of genetic polymorphisms of MTHFR, SLC, and ABC on high-dose methotrexate toxicity and plasma levels in adults with haematological malignancies","volume":"50","author":"Suthandiram","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejps.2017.09.006_bb0180","series-title":"Martindale the Complete Drug Reference","author":"Sweetman","year":"2009"},{"key":"10.1016\/j.ejps.2017.09.006_bb0185","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1182\/blood-2003-12-4428","article-title":"Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma","volume":"104","author":"Thomas","year":"2004","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.ejps.2017.09.006_bb0190","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/FPC.0000000000000069","article-title":"Genetic polymorphisms in candidate genes predict increased toxicity with methotrexate therapy in Lebanese children with acute lymphoblastic leukemia","volume":"24","author":"Zgheib","year":"2014","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.ejps.2017.09.006_bb0195","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1002\/pbc.25191","article-title":"Impact of SLCO1B1 521T>C variant on leucovorin rescue and risk of relapse in childhood acute lymphoblastic leukemia treated with high-dose methotrexate","volume":"61","author":"Zhang","year":"2014","journal-title":"Pediatr. Blood Cancer"},{"issue":"9","key":"10.1016\/j.ejps.2017.09.006_bb0200","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.2217\/pgs-2016-0004","article-title":"MTHFR gene polymorphisms and methotrexate toxicity in adult patients with hematological malignancies: a meta-analysis","volume":"17","author":"Zhao","year":"2016","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ejps.2017.09.006_bb0205","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/tpj.2013.19","article-title":"The role of the MTHFR 677C>T polymorphism in methotrexate-induced liver toxicity: a meta-analysis in patients with cancer","volume":"2","author":"Hagleitner","year":"2014","journal-title":"Pharmacogenomics J."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717304943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717304943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,2]],"date-time":"2022-08-02T02:39:48Z","timestamp":1659407988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098717304943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":39,"alternative-id":["S0928098717304943"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2017.09.006","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Methotrexate pharmacogenetics in Uruguayan adults with hematological malignant diseases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2017.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}